NHS Calderdale Clinical Commissioning Group Logo

Flash glucose monitoring technology soon to be available across Calderdale

Flash glucose monitoring technology soon to be available across Calderdale

Flash Glucose Monitoring uses a small sensor that people wear on their skin. The sensor continuously reads and stores the last eight hours of glucose readings, which can be read by scanning the sensor when required.

This technology has now been approved by NHS Calderdale Clinical Commissioning Group for patients with type 1 diabetes mellitus in the following circumstances:

  • Aged four and above and;
  • Under specialist care and;
  • Using multiple daily injections of insulin, or insulin pump therapy,
  • Whom the specialist considers the use of the device will be cost- effective

and who meet one or more of the following criteria:

  • Meet current NICE criteria for insulin pump therapy (HbA1c ≥69.4 mmol/mol (8.5%) or disabling hypoglycaemia as described in NICE TA151) where a successful trial of a Flash Glucose Monitoring System (FGS) System may avoid the need for pump therapy
  • Recently developed impaired awareness of hypoglycaemia such that there is an inability to detect the onset of hypoglycaemia because of absence of warning symptoms. The individual must also demonstrate a willingness to engage with further education where applicable and a high level of engagement with glucose testing and management. (Note that for persistent hypoglycaemia unawareness, NICE recommends continuous glucose monitoring with alarms and FGS do not currently have this function).
  • Two or more admissions to hospital per year with diabetic ketoacidosis or hypoglycaemia
  • Patients or carer of a patient who have considerable difficulties in finger prick testing due to physical or mental health limitations
  • Patients or carer of a patient with functional impairment that impacts on their ability to interpret standard finger prick testing results

Reluctance to carry out finger prick testing (e.g. due to distress or inconvenience) alone is not considered to be criteria qualifying the use of flash glucose monitoring.

Dr Nigel Taylor, GP Prescribing Lead for Calderdale CCG

Dr Nigel Taylor, GP Prescribing Lead for Calderdale CCG said: “Work is underway to make Flash Glucose Monitoring available to some people with Type 1 Diabetes in Calderdale through an NHS prescription. This should be available in the next month or so.

“Flash Glucose Monitoring will not be available from GPs on prescription; instead patients can discuss their suitability for this technology at their next routine appointment with a specialist from our diabetes team supporting patients in Calderdale.”



Further information


Flash Glucose Monitoring Systems: commissioning statement, funding criteria and patient agreement forms 187.90 KB 69 downloads

A single policy has been agreed by the seven CCGs of the South West Yorkshire Area...
NHS Choices
NHS Constitution
NHS Constitution
Disability Confident Employer Badge

NHS Calderdale Clinical Commissioning Group: 5th floor, F Mill, Dean Clough, Halifax, HX3 5AX. Tel: 01422 307400

| Accessibility | Privacy Notice | Glossary of Terms | Work for us |

Icons provided by Icons8. Free Stock Videos by Videezy

© NHS Calderdale CCG 2019